The worldwide non-opioid ache therapy market valued at USD 13,200.6 million in 2020, and it’s projected to develop at a CAGR of 16.8 % through the forecast interval. Asia Pacific market is anticipated to be the fastest-growing area for the non-opioid ache therapy market.
/EIN News/ — Pune, India, July 14, 2021 (GLOBE NEWSWIRE) — The worldwide non-opioid ache therapy market valued at USD 13,200.6 million in 2020, and it’s projected to develop at a CAGR of 16.8 % through the forecast interval. Non-opioid analgesics are prescribed and over-the-counter (OTC) drugs is used to ease the ache. They’ve change into step by step emphasised in numerous scientific settings as a most well-liked, efficient, and secure first-line remedy substitute to opioid drugs for power ache and gentle to reasonable acute ache.
Get Pattern Copy of This Report @ https://www.quincemarketinsights.com/request-sample-69826
Non-opioid ache therapy entails sturdy ache relievers. This therapy is finished within the place of opioids on account of elevated habit brought on by opioids. They’ve extra negative effects evaluate to non-opioids medicine. Non-opioid medicine are used as a first-line of therapy for acute ache. They’re current in prescribed formulations and over-the-counter remedy to ease ache. With the opioid disaster and lower down on the prescription of opioid painkillers, non-opioids painkillers are the substitute to opioid painkiller. That is anticipated to propel the non-opioids ache therapy market development.
Growing prevalence of power illness will additional propel the non-opioids ache therapy market development. Growing spending on analysis and improvement, present process scientific trials, and alter within the governing surroundings will improve the help for a number of non-opioid medicine which set off the expansion of the non-opioids ache therapy market. Modernized improvement pathway for non-opioid analgesics and partnership among the many main producers for the drug improvement is anticipated to spice up the non-opioids ache therapy market.
Rising prevalence of illnesses, resembling most cancers, arthritis, dental problems, and epilepsy, resulting in power ache situations, resembling migraine, osteoarthritis, decrease again ache, fibromyalgia, localized neuropathic ache, and localized musculoskeletal ache, are driving the worldwide non-opioid ache therapy market development.
Components such because the excessive value of patent medicine and using opioids in quite a few below creating and developed nations will restrain the non-opioid ache therapy market within the forecast interval.
World Non-Opioid Ache Therapy Market, by Product
Primarily based on product, the non-opioid ache therapy market is segmented into medical hashish therapies, capsaicin-derived therapies, menthol-containing therapies, omega-3 fatty acid-containing therapies, and botulinum toxins.
Amongst all product segments of non-opioid ache therapy, the medical hashish therapies section has the quickest market development in 2021 and is anticipated to carry its place through the forecast interval. The section development will be attributed to the growing burden of illnesses, which is anticipated to drives the demand for the medical hashish therapy section through the forecast interval.
Moreover, the growing aged inhabitants which generates excessive demand for healthcare providers, and the excessive demand for hashish for medical use because of the authorized use of medical hashish in developed nations are anticipated to drive the section development through the forecast interval.
World Non-Opioid Ache Therapy Market, by Illness
Primarily based on illness, the non-opioid ache therapy market is segmented into arthritis, most cancers, dental, epilepsy, fibromyalgia, migraine, a number of sclerosis, and surgical. The most cancers section is additional divided into mind, breast, colorectal, leukemia/lymphoma, melanoma, prostate, and others.
The most cancers section has the quickest market development cumulatively in 2021 and is anticipated to stay the quickest section till the forecast interval 2030. The expansion of most cancers section is attributed to non-opioid ache therapy for most cancers sufferers usually current with power ache, which boosts the expansion of non-opioid ache therapy market development within the forecast interval.
As well as, rising consciousness concerning the negative effects related to most cancers therapy like hair loss is anticipated to drive the demand for non-opioid ache therapy within the forecast interval.
World Non-Opioid Ache Therapy Market, by Drug Kind
Primarily based on drug sort, the non-opioid ache therapy market is segmented into acetaminophen, non-steroidal anti-inflammatory medicine, corticosteroids, anticonvulsants, and serotonin-norepinephrine reuptake inhibitor antidepressants. The corticosteroids section holds the biggest section in 2021 and is projected to stay the biggest section through the forecast interval.
Corticosteroids have been proven to lower spontaneous discharge in an injured nerve, which reduces neuropathic ache, which is anticipated to contribute to section development through the forecast interval. As well as, corticosteroids are additionally used to deal with despair, which may increase the market development through the forecast interval.
Purchase Now Full Report @ https://www.quincemarketinsights.com/insight/buy-now/non-opioid-pain-treatment-market/single_user_license
World Non-Opioid Ache Therapy Market, by Distribution Channel
Primarily based on the distribution channel, the non-opioid ache therapy market is segmented into hospital pharmacies, retail pharmacies, drug shops, and on-line pharmacies. The hospital pharmacies section holds the biggest market share in 2021 and is anticipated to stay the biggest market through the forecast interval.
The expansion of the hospital pharmacies section will be attributed to numerous technological developments leading to larger success charges post-treatment and surgical procedures, and the supply of environment friendly affected person care, which is considerably contributing to the hospital pharmacies section development through the forecast interval.
World Non-Opioid Ache Therapy Market, by Area:
Primarily based on area, the non-opioid ache therapy market is segmented into North America, Europe, Asia Pacific, Center East and Africa, and South America. The non-opioid ache therapy market in North America is anticipated to carry the biggest share through the forecast interval owing to favorable regulatory state of affairs.
The important thing issue contributing to the North American market is the growing prevalence of osteoarthritis within the inhabitants. The extended entry to medical care due to healthcare reforms additional propels the regional market. Subsequently, the economies on this area and rising demographics are predictable to supply good alternatives for regional market development.
Asia Pacific market is anticipated to be the fastest-growing area for the non-opioid ache therapy market. The vast majority of the market is generated in much less established nations with relaxed laws concerning hashish. Japan, China, and India are the highest markets for these medicine owing to the excessive demand for higher well being administration and consciousness about ache remedy, and financial situations. As well as, the rising aged inhabitants on this area may also have an effect on the market positively.
Some Latest Developments within the World Non-opioid Ache Therapy Market:
- June 2019- Ironwood Prescription drugs and Allergan began affected person dosing in Part II Medical Trial of MD-7246 in sufferers with stomach ache associated with irritable bowel syndrome with diarrhea (IBS-D). The businesses are evaluating the product, as an oral, intestinal, non-opioid, pain-relieving agent for sufferers affected by stomach ache related to sure GI illnesses.
- June 2018- Sandoz Canada declared partnership settlement with Tilray, a Well being Canada licensed producer of medical hashish to change into the primary Canadian pharmaceutical firm to return into the medical hashish discipline
- January 2018- Centrexion Therapeutics raised USS 67 million and launched Part 3 program for CNTX-4975 in knee osteoarthritis ache. CNTX-4975, ultra-pure, an artificial injection of trans-capsaicin for the therapy of power ache owing to knee osteoarthritis. CNTX-4975 is a novel, extremely differentiated, non-opioid remedy designed to be inserted straight into the painful joint.
COVID-19 Impression on World Non-opioid Ache Therapy Market
The QMI crew is intently observing the impression of COVID-19 on the non-opioid ache therapy market. The nationwide lockdown and steady improve in an infection charges throughout the nation generated a widespread monetary impression on the clinic’s providers. The massive variety of ache and clinic providers has noticed a drop in a number of affected person visits amid COVID-19 in the end dropping shopper contact. Thus, a adverse impression of COVID-19 on the non-opioid ache therapy market is noticed.
Some Main Findings of the World Non-opioid Ache Therapy Market Embody:
- Main international market pattern and forecasts evaluation together with a country-specific market evaluation for as much as 25 nations
- An in-depth international non-opioid ache therapy market evaluation by the aforementioned segments, together with an evaluation of trend-based insights and elements
- Profiles of main market gamers working within the international non-opioid ache therapy market, which embrace Pfizer Inc., Eli Lilly and Firm, Teva Pharmaceutical Industries Ltd., Regeneron Prescription drugs, Centrexion Therapeutics, Novartis AG, US WorldMeds, LLC, GW Prescription drugs plc. Cara Therapeutics, Anodyne Ache, LLC, and Trait Biosciences
- Aggressive benchmarking, product providing particulars, development methods adopted by the main market gamers, together with their main investments within the final 5 years
- Key impression issue evaluation throughout areas that embrace evaluation, together with the drivers, restraints, alternatives, and challenges which are prevailing within the international market
- Impression of COVID-19 on the worldwide non-opioid ache therapy market
Browse key trade insights unfold throughout 165 pages with 85 market knowledge tables and 41 figures & charts from the report, “Non-Opioid Pain Treatment Market, by Product (Medical Hashish Remedies, Capsaicin-derived Remedies, Menthol-containing Remedies, Omega-3 Fatty Acid-Containing Remedies, and Botulinum Toxins), Illness (Arthritis, Most cancers, Dental, Epilepsy, Fibromyalgia, Migraine, A number of Sclerosis, Surgical), Drug Kind (Acetaminophen, Non-Steroidal Anti-Inflammatory Medicine, Corticosteroids, Anticonvulsants, Serotonin Norepinephrine Reuptake Inhibitor Antidepressants), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Shops, On-line Pharmacies), and Area (North America, Europe, Asia Pacific, Center East and Africa, South America) — Market Dimension and Forecasting to 2030” in-depth evaluation together with the desk of contents (ToC).
Enquiry Earlier than Shopping for This Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-69826
Quince Market Insights
Cellphone: US +1 208 405 2835
UK +44 1444 39 0986
APAC +91 706 672 4848
Browse Associated Experiences:
Non-Opioid Ache Patches Market, By Kind (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, and Others), By Distribution Channel (Hospitals Pharmacies, On-line Pharmacies, Drug Shops, and Others), By Area (North America, Jap Europe, Western Europe, Asia Pacific, Center East, Remainder of the World) – Market Dimension & Forecasting (2016-2028)
Hashish Testing Companies Market, By Take a look at Kind (Efficiency Testing, Terpene Profiling, Cannabinoid Profiling, Pesticide Screening, Residual Solvent Testing, Microbiological Screening), Finish Person (Hashish Companies, Homecare Settings, Analysis Institutes) ,and By Area (North America, Western Europe, Jap Europe, Asia Pacific, Center East, and the Remainder of the World) – Market Dimension & Forecasting (2017-2028).
World Authorized Hashish Market, By Compound (THC-Dominant, CBD-Dominant, Balanced THC, and CBD), By Software (Medical, Leisure), By Kind (Flowers, Concentrates), By Area (North America, South America, Europe, and Remainder of the World) – Market Dimension & Forecasting (2016-2028)
Topical Ache Aid Market, By Therapeutic Class (Non-Opioids, Opioids), By Kind (Prescription Ache Aid, Over-the-Counter Ache Aid), By Formulation (Cream, Gel, Spray, Patch, Others), By Distribution Channel (Pharmacies & Drug Shops, e-Commerce, Retail & Grocery Shops), By Area (North America, Western Europe, Jap Europe, Asia Pacific, Center East, Remainder of the World) – Market Dimension & Forecasting (2016-2028)
Opioids Market, By Product (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone, Others), By Software (Ache Administration, Cough Therapy, Diarrhea), By Area (North America, Jap Europe, Western Europe, Asia Pacific, Center East, Remainder of the World) – Market Dimension & Forecasting (2016-2028)